The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia.
Journal Information
Full Title: Ther Adv Hematol
Abbreviation: Ther Adv Hematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"The authors declare that there is no conflict of interest."
Funding Disclosure
Evidence found in paper:
"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Farhad Ravandi, Guillermo Garcia-Manero and Hagop Kantarjian have all received research funding from Astex Pharmaceuticals. Farhad Ravandi has also received funding and honoraria from Taiho Pharmaceuticals."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025